FindMyRecallSubscribe
Class III: unlikely to cause harmTerminated

Sato Pharmaceutical Sankaijo BOTANICAL LAXATIVE Recall

Sankaijo BOTANICAL LAXATIVE (docusate sodium 8

Sato Pharmaceutical Inc. · Torrance, CA

Risk level
Class III
Reported by FDA
Nov 13, 2019
Recall ID
D-0303-2020
Check your lot numberHow we source this data

Summary

Sato Pharmaceutical recalled Sankaijo BOTANICAL LAXATIVE starting Oct 1, 2019. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-0303-2020 on Nov 13, 2019. Reason: Subpotent Drug: Formulated amount of sennosides component is less than labelled claim. Status: Terminated.

Why it was recalled

Subpotent Drug: Formulated amount of sennosides component is less than labelled claim.

Product description

Sankaijo BOTANICAL LAXATIVE (docusate sodium 8.33 mg and sennosides 1.36 mg) tablets, 150-count bottles, Manufactured by SATO PHARMACEUTICAL CO., LTD., 1-5-27 Motoakasaka Minato-KU Tokyo, Japan; SATO PHARMACEUTICAL, INC., 20695 S. Western Ave., Suite 240, Torrance, CA 90501; NDC 49873-404-01.

Lot numbers, UPCs & expiration codes

Lot #: TXWT, Exp 01/20; TXTS, Exp 10/20; AXWS, Exp 10/21

Where it was sold

Nationwide in the USA and Guam and Saipan, Northern Mariana Islands

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0303-2020
Classification
Class III
Status
Terminated
Recall initiated
Oct 1, 2019
FDA report date
Nov 13, 2019
Quantity
17,284 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Sato Pharmaceutical Inc.

Original FDA data

Every field from FDA enforcement report D-0303-2020, exactly as published.

Show all FDA fields
City
Torrance
State
CA
Status
Terminated
Country
United States
Event ID
84019
Address
20695 S Western Ave Ste 240
Code information
Lot #: TXWT, Exp 01/20; TXTS, Exp 10/20; AXWS, Exp 10/21
Postal code
90501-1834
Report date
Nov 13, 2019
Product type
Drugs
Recall number
D-0303-2020
Classification
Class III
Recalling firm
Sato Pharmaceutical Inc.
Product quantity
17,284 bottles
Termination date
Aug 18, 2020
Reason for recall
Subpotent Drug: Formulated amount of sennosides component is less than labelled claim.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Sankaijo BOTANICAL LAXATIVE (docusate sodium 8.33 mg and sennosides 1.36 mg) tablets, 150-count bottles, Manufactured by SATO PHARMACEUTICAL CO., LTD., 1-5-27 Motoakasaka Minato-KU Tokyo, Japan; SATO PHARMACEUTICAL, INC., 20695 S. Western Ave., Suite 240, Torrance, CA 90501; NDC 49873-404-01.
Distribution pattern
Nationwide in the USA and Guam and Saipan, Northern Mariana Islands
Recall initiation date
Oct 1, 2019
Initial firm notification
Letter
Center classification date
Nov 7, 2019

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0303-2020, published Nov 13, 2019. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls